Catalyst Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CPRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 Dec 25	SellUS$155,563	Molly Harper	Individual	6,746	US$23.06
12 Nov 25	SellUS$908,000	Brian Elsbernd	Individual	40,000	US$22.70
11 Jun 25	SellUS$103,649	Preethi Sundaram	Individual	3,924	US$26.42
09 Jun 25	SellUS$5,217,338	Patrick McEnany	Individual	200,000	US$26.11
30 May 25	SellUS$1,740,200	Richard John Daly	Individual	70,000	US$24.86
03 Mar 25	SellUS$696,382	Jeffrey Del Carmen	Individual	30,423	US$22.89
03 Mar 25	SellUS$10,454	Brian Elsbernd	Individual	450	US$23.23

Insider Trading Volume

Insider Buying: CPRX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CPRX?
Owner Type	Number of Shares	Ownership Percentage
State or Government	49,427	0.0402%
Individual Insiders	7,464,715	6.07%
General Public	9,904,703	8.06%
Institutions	105,493,542	85.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 60.74% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.8%	BlackRock, Inc.	18,216,060	US$445.4m	-3.62%	0.01%
7.09%	The Vanguard Group, Inc.	8,713,520	US$213.0m	-0.6%	no data
5.21%	State Street Global Advisors, Inc.	6,405,387	US$156.6m	16.9%	no data
4.05%	Deerfield Management Company, L.P.	4,974,767	US$121.6m	72.8%	1.47%
3.38%	Patrick McEnany	4,152,011	US$101.5m	-3.03%	no data
2.88%	Renaissance Technologies LLC	3,544,830	US$86.7m	9.02%	0.11%
2.74%	Fundsmith, LLP	3,363,807	US$82.2m	24.2%	0.31%
2.35%	Geode Capital Management, LLC	2,890,320	US$70.7m	0.82%	no data
2.06%	American Century Investment Management Inc	2,528,186	US$61.8m	43.8%	0.02%
2%	Dimensional Fund Advisors LP	2,458,169	US$60.1m	28.9%	0.01%
1.66%	Royce & Associates, LP	2,034,965	US$49.8m	28.6%	0.44%
1.24%	Morgan Stanley	1,527,328	US$37.3m	-45.3%	no data
1.08%	Charles Schwab Investment Management, Inc.	1,331,990	US$32.6m	-7.25%	no data
1.06%	Arrowstreet Capital, Limited Partnership	1,304,774	US$31.9m	6.63%	0.02%
1.05%	Boston Partners Global Investors, Inc.	1,291,059	US$31.6m	0.65%	0.02%
1.03%	Northern Trust Global Investments	1,263,888	US$30.9m	-0.88%	no data
0.96%	Millennium Management LLC	1,179,182	US$28.8m	174%	0.02%
0.89%	Invesco Capital Management LLC	1,097,993	US$26.8m	1.2%	0.01%
0.88%	Steven Miller	1,079,803	US$26.4m	1.9%	no data
0.86%	Kennedy Capital Management LLC	1,060,207	US$25.9m	5.03%	0.55%
0.74%	Managed Account Advisors LLC	914,124	US$22.4m	20.4%	no data
0.71%	UBS Asset Management AG	870,910	US$21.3m	-39.1%	no data
0.67%	Merrill Lynch, Pierce, Fenner & Smith Incorporated	828,688	US$20.3m	-28.1%	0.01%
0.67%	Qube Research & Technologies Ltd	821,202	US$20.1m	-19.1%	0.03%
0.65%	Allianz Asset Management GmbH	797,948	US$19.5m	-23%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/26 20:19
End of Day Share Price	2025/12/24 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Catalyst Pharmaceuticals, Inc. is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Luke Herrmann	Baird
Joel Beatty	Baird
null null	Baird